Research into 'silent' adrenal tumors detected by CT scans provides much-needed guidance for clinical management

January 28, 2014

CT scans are increasingly performed for a variety of medical indications, including for general health screening, which is growing in popularity. An estimated 4 percent of CT scans will coincidentally uncover a tumor in the adrenal gland, with no associated clinical symptoms.

However, until now, evidence on how to manage these 'silent' tumours has been lacking, despite the fact that the growing demand for CT scans is likely to lead to increasing numbers of detections.

A new study in The Lancet Diabetes & Endocrinology is one of the first to shed light on the progression of these tumours, and should help clinicians and patients to decide how to manage them. The study rigorously assesses how 'silent' adrenal tumours (adrenal incidentalomas) affect patients' risk of cardiovascular events and death. The results show that over time, some tumours became more active, and that is elevated in many patients with tumours, especially in those patients whose tumours secrete the hormone cortisol.

Currently, management of these tumours can be very expensive because insufficient information exists to enable treatment strategies to be tailored to each patient. According to lead author Professor Renato Pasquali, of the S Orsola-Malpighi Hospital, in Bologna, Italy, "Our findings are important because they add to the previously scant information about adrenal incidentalomas, which will be of use to doctors who are seeing an increasing number of patients with these masses."

Writing in a linked Comment, Professor Rosario Pivonello, of the Università Federico II in Naples, Italy, says that, "The study findings underline that the degree of hormonal dysfunction can worsen during follow-up…[and] support the importance of long-term hormonal follow-up for clinical management of all patients with adrenal incidentalomas. Furthermore, clinical monitoring of cardiometabolic risks seems to be important in these , particularly in those with [secreting tumours], for whom medical or surgical intervention could be needed."

Explore further: Scientists develop urine test for cancer

More information:

Related Stories

Scientists develop urine test for cancer

September 16, 2011

Scientists at the University of Birmingham have developed a ground-breaking technique that uses a urine test to help to diagnose adrenal cancer.

Cancer treatment could target inflammation in CVD

May 5, 2013

Peptide receptor radionuclide therapy (PRRT) with radiolabeled somatostatin analogs, an established treatment for cancer patients, could offer a novel therapeutic approach to decrease levels of inflammation in the atherosclerotic ...

Are you carrying adrenal Cushing's syndrome without knowing it?

November 27, 2013

Genetic research that will be published tomorrow in the New England Journal of Medicine suggests to Dr. André Lacroix, professor at the University of Montreal, that clinicians' understanding and treatment of a form of Cushing's ...

Recommended for you

Elephants provide big clue in fight against cancer

October 9, 2015

Carlo Maley spends his time pondering pachyderms—and cactuses and whales, and a wide array of non-human species—all in pursuit of the answer to this question: Why do some life forms get cancer while others do not?

Compound doubles up on cancer detection

October 8, 2015

Tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer, according to a study published last week in the Proceedings of the ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.